483 Response Amgen Aug 2004

Mihaly Ligmond FDA, Ann Montemurro FDA$119.00 - Available Now

FDA investigators audited the Amgen - Boulder, CO, United States facility and issued inspectional observation (via FDA 483) on 27 Aug 2004.

Product details

  • Category:
  • Inspection end: 27 Aug 2004
  • Location: Boulder, United States
  • FEI: 3003072024
Add To Cart